| Literature DB >> 29337674 |
Jie-Bin Zhou1, Ying-Ying Sun2, Ying-Lin Zheng1, Chu-Qin Yu2, Hua-Qing Lin2, Ji-Yan Pang1.
Abstract
In this study, the effect of four xyloketals 1-4 on store-operated calcium entry (SOCE) was investigated in primary distal pulmonary arterial smooth muscle cells (PASMCs) isolated from mice. The results showed that xyloketal A (1), an unusual ketal with C-3 symmetry, exhibited strong SOCE blocking activity. Secretion of interleukin-8 (IL-8) was also inhibited by xyloketal A. The parallel artificial membrane permeability assay (PAMPA) of 1-4 suggested that these xyloketals penetrated easily through the cell membrane. Moreover, the molecular docking study of xyloketal A with activation region of the stromal interaction molecule (STIM) 1 and the calcium release-activated calcium modulator (ORAI) 1 (STIM1-ORAI1) protein complex, the key domain of SOCE, revealed that xyloketal A exhibited a noncovalent interaction with the key residue lysine 363 (LYS363) in the identified cytosolic regions in STIM1-C. These findings provided useful information about xyloketal A as a SOCE inhibitor for further evaluation.Entities:
Keywords: IL-8; molecular docking; parallel artificial membrane permeability assay; store-operated calcium entry; xyloketal A
Mesh:
Substances:
Year: 2017 PMID: 29337674 DOI: 10.1515/acph-2017-0032
Source DB: PubMed Journal: Acta Pharm ISSN: 1330-0075 Impact factor: 2.230